Integra LifeSciences Holdings C

Historical 13F Holders

Symbol
IART
CUSIP
457985208
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 457985208 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 13.2% 7/17/2025
Event 6/30/2025
Rubric Capital Management LP 13G/A
9.5% 7/9/2025
Event 6/30/2025
Invesco Ltd. 13G 5.4% 11/10/2026
Event 9/30/2026
Vanguard Portfolio Management LLC 13G 5.0% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Fuller & Thaler Asset Management, Inc. 13G/A 4.7% 2/17/2026
Event 12/31/2025
Morgan Stanley 13G/A 4.3% 8/5/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026
Paradigm Capital Management Inc/NY 13G/A
Checked 5% or less
8/13/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 234 74.1 M $1.20B
2026 Q2 212 73.3 M $1.32B
2026 Q1 202 74.8 M $705M
2025 Q4 205 74.0 M $920M
2025 Q3 208 72.8 M $1.04B
2025 Q2 211 73.1 M $897M
2025 Q1 221 73.5 M $1.62B
2024 Q4 224 69.3 M $1.57B
2024 Q3 226 70.4 M $1.24B
2024 Q2 239 71.0 M $2.07B
2024 Q1 281 66.0 M $2.34B
2023 Q4 284 66.9 M $2.92B
2023 Q3 266 68.8 M $2.63B
2023 Q2 285 69.2 M $2.85B
2023 Q1 281 72.8 M $4.18B
2022 Q4 283 75.0 M $4.20B
2022 Q3 285 73.8 M $3.13B
2022 Q2 287 73.1 M $3.95B
2022 Q1 279 74.7 M $4.80B
2021 Q4 279 77.4 M $5.19B
2021 Q3 262 76.9 M $5.27B
2021 Q2 266 74.8 M $5.10B
2021 Q1 261 73.8 M $5.10B
2020 Q4 256 74.1 M $4.81B
2020 Q3 240 72.7 M $3.43B
2020 Q2 266 72.2 M $3.39B
2020 Q1 262 71.7 M $3.20B
2019 Q4 280 70.7 M $4.12B
2019 Q3 282 69.2 M $4.16B
2019 Q2 265 70.7 M $3.95B
2019 Q1 261 71.1 M $3.96B
2018 Q4 252 71.5 M $3.23B
2018 Q3 253 74.3 M $4.89B
2018 Q2 257 72.8 M $4.69B
2018 Q1 236 70.5 M $3.90B
2017 Q4 221 71.4 M $3.42B
2017 Q3 214 69.3 M $3.50B
2017 Q2 225 66.8 M $3.63B
2017 Q1 238 68.3 M $2.88B
2016 Q4 227 34.7 M $2.96B
2016 Q3 237 33.3 M $2.75B
2016 Q2 211 33.4 M $2.67B
2016 Q1 194 32.9 M $2.22B
2015 Q4 185 31.7 M $2.15B
2015 Q3 189 30.9 M $1.84B
2015 Q2 188 27.1 M $1.83B
2015 Q1 170 27.6 M $1.70B
2014 Q4 160 26.4 M $1.43B
2014 Q3 144 26.3 M $1.30B
2014 Q2 147 26.2 M $1.23B
2014 Q1 145 25.7 M $1.18B